Structural Studies of Pterin-Based Inhibitors of Dihydropteroate Synthase

Journal of Medicinal Chemistry
2010.0

Abstract

Dihydropteroate synthase (DHPS) is a key enzyme in bacterial folate synthesis and the target of the sulfonamide class of antibacterials. Resistance and toxicities associated with sulfonamides have led to a decrease in their clinical use. Compounds that bind to the pterin binding site of DHPS, as opposed to the p-amino benzoic acid (pABA) binding site targeted by the sulfonamide agents, are anticipated to bypass sulfonamide resistance. To identify such inhibitors and map the pterin binding pocket, we have performed virtual screening, synthetic, and structural studies using Bacillus anthracis DHPS. Several compounds with inhibitory activity have been identified, and crystal structures have been determined that show how the compounds engage the pterin site. The structural studies identify the key binding elements and have been used to generate a structure-activity based pharmacophore map that will facilitate the development of the next generation of DHPS inhibitors which specifically target the pterin site.

Knowledge Graph

Similar Paper

Structural Studies of Pterin-Based Inhibitors of Dihydropteroate Synthase
Journal of Medicinal Chemistry 2010.0
Pterin–sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents
Bioorganic & Medicinal Chemistry Letters 2016.0
Crystal Structure of the Anthrax Drug Target, Bacillus anthracis Dihydrofolate Reductase
Journal of Medicinal Chemistry 2007.0
New acrylamide-sulfisoxazole conjugates as dihydropteroate synthase inhibitors
Bioorganic & Medicinal Chemistry 2020.0
The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase
Bioorganic & Medicinal Chemistry 2014.0
Synthetic and Crystallographic Studies of a New Inhibitor Series Targeting Bacillus anthracis Dihydrofolate Reductase
Journal of Medicinal Chemistry 2008.0
Crystal Structure of Bacillus anthracis Dihydrofolate Reductase with the Dihydrophthalazine-Based Trimethoprim Derivative RAB1 Provides a Structural Explanation of Potency and Selectivity
Antimicrobial Agents and Chemotherapy 2009.0
Targeted Mutations of Bacillus anthracis Dihydrofolate Reductase Condense Complex Structure−Activity Relationships
Journal of Medicinal Chemistry 2010.0
Monocyclic pteridine analogs. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines
Journal of Medicinal Chemistry 1985.0
Structure-activity relationships in dihydropteroate synthase inhibition by sulfanilamides. Comparison with the antibacterial activity
Journal of Medicinal Chemistry 1981.0